Journal News

From the journals: JBC

Isabel Casas
Sept. 16, 2022

Secrets of spider silk proteins. Potential Alzheimer’s target treatments. Structure of a deadly virulence factor. Read about papers on these topics recently published in the Journal of Biological Chemistry.

Secrets of spider silk proteins

Spider silk is remarkable stuff.

Orb-weaving spiders can produce up to seven types of silk for different purposes, and the silk’s mechanical properties — including tensile strength and elasticity — are like nothing humankind has created. That’s why there’s a lot of interest among researchers in both using the material and learning from it.

Spiders synthesize silk in a dedicated gland. The polymer building blocks — known as spidroins — can be made of thousands of amino acid residues with highly repetitive regions, including flanking globular N- and C- terminal globular domains, which regulate silk formation.

The N-terminal domain of these spider silk proteins is essential for storage and silk assembly. Researchers have scrutinized the N-terminal domains of the major and minor ampullate spidroins (MaSp and MiSp, respectively) and found them to be monomeric at neutral pH. However, at lower pHs, they dimerize to connect spidroins in a fiber.

In a recent Journal of Biological Chemistry article, Médoune Sarr and colleagues at the Karolinska Institute and colleagues from the Latvian Institute of Organic Chemistry reported the structure of the N-terminal domain of flagelliform spidroin both in solution and in crystal forms.

The authors show that it is structurally similar to the N-terminal domain of the MaSp and that protonation events affecting interaction involve specific amino acid residues different from those in MaSp NT. The authors conclude that the overall mechanism of pH-dependent dimerization is conserved, although it can be mediated by different pathways in different silk types.

Potential Alzheimer’s target treatments

Alzheimer’s disease is the most prevalent form of dementia. It affects millions of people over the age of 65 in the United States alone. It is characterized by extracellular plaques in the brain consisting of neurotoxic amyloid beta-peptides — Aβ — and intraneuronal hyperphosphorylated Tau protein aggregates.

While the production of Aβ from amyloid precursor protein, or APP, could be diminished by enhancing alpha-processing, the physical interactions between APP and α-secretases remain to be understood.

Lisa Hitschler and Thorsten Lang at the University of Bonn in Germany recently used super-resolution light microscopy to examine the abundance and association of APP and α-secretases ADAM10 and ADAM17 in cell-free plasma membranes.

They found that both secretases localize closely to APP. However, only ADAM10 co-aggregated with APP. They also identified the transmembrane domain in APP required for association with α-secretases.

The researchers propose that the APP transmembrane domain interacts either directly or indirectly with ADAM10 but not with ADAM17. They suggest this interaction could help in the development of therapies based upon promoting APP cleavage by α-secretases.

They reported their study in the Journal of Biological Chemistry.

Structure of a deadly virulence factor

Enterococcus faecalis is a nosocomial pathogen that lives in the human gastrointestinal tract and is responsible for a wide range of infections that can be life threatening. The E. faecalis N-acetylglucosaminidase AtlA plays a predominant role in cell separation.

In a zebrafish model, atlA mutants are less virulent due to a limited dissemination of bacterial chains in the host organism and a more efficient uptake by phagocytes that clear the infection. Other pathogens — including Listeria monocytogenes and Salmonella typhimurium — have structural homologs to AtlA, making it attractive to researchers interested in designing new inhibitors to bacterial pathogenesis.

In a recent paper in the Journal of Biological Chemistry, co–first authors Véronique Roig–Zamboni and Sarah Barelier, along with their colleagues in France, reported a 1.6 Å crystal structure of the E. faecalis AtlA catalytic domain. The team revealed a closed conformation of a conserved beta-hairpin and a complex network of hydrogen bonds that bring two catalytic residues to the ideal distance for an inverting mechanism. The authors suggest that this structure will inform rational drug design targeting this enterococcal virulence factor and even orthologs in other pathogens.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Isabel Casas

Isabel Casas is the ASBMB’s publications director.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.